Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Cancer Consult . Volume 2. : Expertise in Clinical Practice / / edited by Syed A. Abutalib [and three others]
| Cancer Consult . Volume 2. : Expertise in Clinical Practice / / edited by Syed A. Abutalib [and three others] |
| Edizione | [Second edition.] |
| Pubbl/distr/stampa | Chichester, England : , : John Wiley & Sons Ltd, , [2024] |
| Descrizione fisica | 1 online resource (863 pages) |
| Disciplina | 616.99/418 |
| Soggetto topico |
Hematopoietic system - Cancer
Hematological oncology Cellular therapy |
| ISBN |
1-119-82319-6
1-119-82320-X |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- Cancer Consult -- Contents -- Editors Volume 2 -- Preface -- Author Bios -- Acknowledgement -- Part 1 Acute Lymphoblastic Leukemia in Adults -- 1 Prognostic Markers and Models in Acute Lymphoblastic Leukemia -- 2 Acute Lymphoblastic Leukemia-Treatment and Outcomes in B-ALL -- 3 T Cell Acute Lymphoblastic Leukemia and Acute Lymphoblastic Lymphoma -- 4 Minimal Residual Disease in Acute Lymphoblastic Leukemia -- 5 Hematopoietic Transplantation and Cellular Therapy in Acute Lymphoblastic Leukemia -- Part 2 Acute Myeloid Leukemia in Adults -- 6 Prognosis in Acute Myeloid Leukemia: Beyond Cytogenetics -- 7 Young Adults with Acute Myeloid Leukemia -- 8 Older Adults with Acute Myeloid Leukemia -- 9 Acute Promyelocytic Leukemia -- 10 Measurable Residual Disease in Acute Myeloid Leukemia -- 11 Hematopoietic Cell Transplantation and Cellular Therapy in Acute Myeloid Leukemia -- Part 3 Myelodysplastic Syndromes and Familial Myeloid Neoplasms -- 12 Diagnosis of Myelodysplastic Syndromes -- 13 Treatment of Myelodysplastic Syndromes -- 14 Hematopoietic Cell Transplantation and Cellular Therapy in Myelodysplastic Syndromes -- 15 Familial Myeloid Neoplasms-When to Suspect and What to Do? -- Part 4 Myeloproliferative Neoplasms -- 16 Chronic Myeloid Leukemia: Chronic Phase Disease -- 17 Chronic Myeloid Leukemia: Advance Phases of the Disease -- 18 Chronic Myeloid Leukemia: Treatment Safety During Reproductive Age and Pregnancy -- 19 Chronic Myeloid Leukemia: Cessation of Therapy -- 20 Hematopoietic Cell Transplantation in Chronic Myeloid Leukemia -- 21 Polycythemia Vera -- 22 Essential Thrombocythemia -- 23 Primary Myelofibrosis -- 24 Hematopoietic Cell Transplantation and Cellular Therapy in Primary and Post ET/PV Myelofibrosis -- 25 Chronic Myelomonocytic Leukemia -- 26 Eosinophilic Myeloproliferative Disorders.
Part 5 Chronic Lymphocytic and Other Leukemias -- 27 Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma -- 28 Hematopoietic Cell Transplantation and Cellular Therapy in Chronic Lymphocytic Leukemia -- 29 Prolymphocytic Leukemia -- 30 Hairy Cell Leukemia -- Part 6 Hodgkin Lymphoma -- 31 Classic Hodgkin Lymphoma -- 32 Nodular Lymphocyte-Predominant Hodgkin Lymphoma -- 33 Hematopoietic Cell Transplantation and Cellular Therapy in Hodgkin Lymphoma -- Part 7 Non-Hodgkin's Lymphomas -- 34 Pitfalls in the Diagnosis of Non-Hodgkin's Lymphomas -- 35 Follicular Lymphoma -- 36 Mantle Cell Lymphoma -- 37 Marginal Zone Lymphoma -- 38 Hematopoietic Cell Transplantation and Cellular Therapy in Indolent Non-Hodgkin's Lymphomas -- 39 Diffuse Large B Cell Lymphoma -- 40 Hematopoietic Cell Transplantation and Cellular Therapy in Diffuse Large B Cell Lymphoma -- 41 Primary Mediastinal Large B Cell Lymphoma -- 42 Double-Hit and Double-Expressor Lymphomas -- 43 Transformed Lymphoma -- 44 Burkitt Lymphoma -- 45 Primary and Secondary CNS Lymphomas -- 46 HIV-Associated Lymphoma -- 47 Waldenström's Macroglobulinemia -- 48 Primary Cutaneous Lymphomas -- 49 Mycosis Fungoides and Sézary Syndrome -- 50 Peripheral T-Cell Lymphoma -- Part 8 Plasma Cell Neoplasms and Related Disorders -- 51 Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma -- 52 Risk Stratification Including Measurable Residual Disease in Multiple Myeloma -- 53 Newly Diagnosed Multiple Myeloma: Transplant Eligible -- 54 Newly Diagnosed Multiple Myeloma: Transplant Ineligible -- 55 Relapsed/Refractory Multiple Myeloma -- 56 Light-chain (AL) Amyloidosis -- 57 Bispecific T Cell Engager and Cell Based Immune Therapy in Multiple Myeloma -- Part 9 Special Issues in Neoplastic Hematology and Cellular Therapy -- 58 Treatment of Lymphomas During Pregnancy. 59 Complications and Management of CAR T Cell Therapy -- 60 Acute Graft-versus-Host Disease -- 61 Chronic Graft-versus-Host Disease -- Index -- EULA. |
| Record Nr. | UNINA-9910829819503321 |
| Chichester, England : , : John Wiley & Sons Ltd, , [2024] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Clinical advances in hematology & oncology : H & O
| Clinical advances in hematology & oncology : H & O |
| Pubbl/distr/stampa | New York, NY, : Millennium Medical Pub., ©2003- |
| Descrizione fisica | 1 online resource |
| Disciplina | 616 |
| Soggetto topico |
Hematology
Hematological oncology Oncology Blood - Diseases Hematologic Diseases - therapy Neoplasms - therapy Medical Oncology |
| Soggetto genere / forma | Periodicals. |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Altri titoli varianti |
Clinical advances in hematology and oncology
Hematology & oncology H & O |
| Record Nr. | UNINA-9910154555503321 |
| New York, NY, : Millennium Medical Pub., ©2003- | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Flow cytometry of hematological malignancies / / Claudio Ortolani
| Flow cytometry of hematological malignancies / / Claudio Ortolani |
| Autore | Ortolani C (Claudio) |
| Edizione | [Second edition.] |
| Pubbl/distr/stampa | Hoboken, New Jersey ; ; Chichester, West Sussex, England : , : Wiley Blackwell, , [2021] |
| Descrizione fisica | 1 online resource (467 pages) |
| Disciplina | 574.87028 |
| Soggetto topico |
Flow cytometry
Hematological oncology Flow cytometry - Methodology |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-119-61130-X
1-119-61127-X 1-119-61128-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover -- Title Page -- Copyright Page -- Contents -- Foreword to the Second Edition -- Foreword to the First Edition -- Foreword to the First Edition -- Preface to the Second Edition -- Preface to the First Edition -- Abbreviations -- Chapter 1 Antigens -- CD1 Antigens -- CD2 Antigen -- CD3 Antigen -- CD4 Antigen -- CD5 Antigen -- CD7 Antigen -- CD8 Antigen -- CD10 Antigen -- CD11b Antigen -- CD11c Antigen -- CD13 Antigen -- CD14 Antigen -- CD15 Antigen -- CD16 Antigen -- CD19 Antigen -- CD20 Antigen -- CD22 Antigen -- CD23 Antigen -- CD24 Antigen -- CD25 Antigen -- CD26 Antigen -- CD27 Antigen -- CD28 Antigen -- CD30 Antigen -- CD33 Antigen -- CD34 Antigen -- CD38 Antigen -- CD43 Antigen -- CD45 Antigen -- CD45 Isoforms -- CD49 Antigens -- CD56 Antigen -- CD57 Antigen -- CD61 Antigen -- CD62L Antigen -- CD64 Antigen -- CD65 Antigen -- CD66c Antigen -- CD71 Antigen -- CD79 Antigen -- CD81 Antigen -- CD103 Antigen -- CD117 Antigen -- CD123 Antigen -- CD138 Antigen -- CD200 Antigen -- CD305 Antigen -- CD307 (IRTA) Family -- CD371 Antigen -- BCL-2 Protein -- Chemokines and Chemokine Receptors -- Chemokines -- Chemokine Receptors -- CRLF2 Antigen -- Cytotoxic Proteins -- HLA-DR Antigen -- Immunoglobulins -- KIRs, CD158 Isoforms -- Myeloperoxidase -- NG2 Antigen -- PCA-1 Antigen -- ROR1 Antigen -- SLAM Molecules and SLAM-Associated Protein -- SOX11 -- T-Cell Receptor (TCR) -- Terminal Deoxy-Nucleotidyl Transferase -- Toll-Like Receptors -- VS38 Antigen -- ZAP-70 Protein -- Chapter 2 Diseases -- Myeloproliferative neoplasms -- Chronic myeloid leukemia (CML) -- Myeloproliferative neoplasms other than CML -- Chronic neutrophilic leukemia (CNL) -- Polycythemia vera (PV) -- Primary myelofibrosis (PMF) -- Essential thrombocythemia (ET) -- Chronic eosinophilic leukemia (CEL) -- Mastocytosis -- Acute mast-cell leukemia (AMCL).
Chronic mast-cell leukemia (CMCL) -- Myelomastocytic leukemia (MML) -- Myelodysplastic/myeloproliferative neoplasms -- Chronic myelomonocytic leukemia (CMML) -- Other myelodysplastic/myeloproliferative neoplasms and related conditions -- Juvenile myelomonocytic leukemia (JMML) -- Atypical CML bcr/abl negative (ACML) -- RAS-associated autoimmune leukoproliferative disorder (RALD) -- Myelodysplastic syndromes -- Myeloid neoplasms with germline predisposition -- Acute myeloid leukemias -- AMLs with recurrent genetic anomalies -- AMLs with chromosomal anomalies -- AMLs with gene mutations -- Relationships between genotype and phenotype in cases of AML not recognized as separate entities in WHO 2017 -- AMLs with myelodysplasia-related changes (AML-MRC) -- AMLs not otherwise specified -- AML with minimal differentiation -- AML without maturation -- AML with maturation -- Acute myelomonocytic leukemia (AMMoL) -- Acute monoblastic and monocytic leukemia (AMoL) -- Pure erythroid leukemia (PEL) -- Acute megakaryoblastic leukemia (AMKL) -- Acute basophilic leukemia (ABL) -- Myeloid proliferations associated with Down syndrome -- Transient abnormal myelopoiesis (TAM) -- AMLs in patients with Down syndrome -- Blastic plasmacytoid dendritic cell neoplasm (BPDCN/PDCL) -- Acute leukemias with ambiguous lineage attribution (ALAL) -- Acute undifferentiated leukemias (AUL) -- Mixed phenotype acute leukemias (MPAL) -- Neoplastic diseases of B and T lymphatic precursors -- B lymphoblastic leukemia/lymphoma, not otherwise specified (B-ALL/LBLnos) -- B lymphoblastic leukemia/lymphoma with recurrent genetic anomalies -- Relationships between genotype and phenotype in cases of B-ALL not recognized as separate entities in WHO 2017 -- T lymphoblastic leukemia/lymphoma (T-ALL/LBL) -- Early T-cell precursor lymphoblastic leukemia (ETP-ALL). NK lymphoblastic leukemia/lymphoma (NK-ALL/LBL) -- Neoplastic diseases of mature B cells -- Chronic lymphocytic leukemia/small lymphocytic lymphoma (B-CLL/SLL) -- Familial B-CLL -- Richter syndrome -- Monoclonal B-cell lymphocytosis (MBL) -- CLL-like monoclonal B lymphocytosis -- Non-CLL-like monoclonal B lymphocytosis -- B-cell prolymphocytic leukemia (B-PLL) -- Lymphoplasmacytic lymphoma (LPL) -- Heavy chain disease (HCD) -- μ heavy chain disease -- α heavy chain disease -- Hairy cell leukemia (HCL) -- Hairy cell leukemia, variant (HCL-v) -- Hairy cell leukemia, Japanese variant (HCL-J) -- Splenic diffuse red pulp lymphoma (SDRPL) -- Marginal zone lymphomas (MZL) -- Nodal marginal zone lymphoma (NMZL) -- Splenic marginal zone lymphoma (SMZL) -- Extranodal marginal zone lymphoma (EMZL/MALToma) -- Clonal B-cell lymphocytosis with MZL-like phenotype (CBL-MZ) -- Follicular lymphoma (FCL) -- Testicular follicular lymphoma -- Duodenal type follicular lymphoma -- Pediatric type follicular lymphoma -- Primitive cutaneous follicular lymphoma (PCFL) -- Large B-cell lymphoma with IRF4 rearrangement -- Mantle-cell lymphoma (MCL) -- Blastic mantle-cell lymphoma (BMCL) -- Leukemic non nodal mantle-cell lymphoma -- DLBCL not otherwise specified (DLBCLnos) -- CD5(+) diffuse large cell lymphoma (CD5(+) DLBCL) -- T-cell/histiocyte-rich B-cell lymphoma (THRLBCL) -- Primary DLBCL of the CNS (PCNSL) -- Primary cutaneous DLBCL, "leg type -- EBV(+) DLBCLnos -- DLBCL associated with chronic inflammation (PAL) -- Fibrin associated DLBCL -- Lymphomatoid granulomatosis (LYG) -- Primary mediastinal B-cell lymphoma (PMBCL) -- Intravascular large B-cell lymphoma (IVBCL) -- ALK-positive large cell lymphoma (ALK(+) LBCL) -- Plasmablastic lymphoma (PBL) -- Primary effusion lymphoma (PEL) -- HHV8-associated lymphoproliferative disorders -- HHV8-positive DLBCL. HHV8-positive germinotropic lymphoproliferative disorder -- Burkitt lymphoma (BL) -- Burkitt leukemia with immature phenotype -- Burkitt-like lymphoma with 11q aberrations -- High-grade B-cell lymphoma (HGBL) -- Plasma cell neoplasms -- Monoclonal gammopathies of undetermined significance (MGUS) -- Multiple myeloma (MM) -- Plasma cell leukemia (PCL) -- Neoplastic diseases of mature T and NK cells -- T-cell prolymphocytic leukemia (T-PLL) -- T-cell large granular lymphocytic leukemia (T-LGL) -- Chronic lymphoproliferative disorders of NK cells (CLPD-NK/CNKL) -- Aggressive NK-cell leukemia (ANKL) -- Adult T-cell leukemia/lymphoma (ATLL) -- Extranodal NK/T-cell lymphoma, "nasal type" (ENKTL) -- Intestinal T-cell lymphomas (ITCL) -- Enteropathy-associated T-cell lymphoma (EATCL) -- Monomorphic epitheliotropic intestinal T-cell lymphoma (MEITL) -- Indolent gastro-intestinal T lymphoproliferative disorder (indolent GI T-LPD) -- Hepatosplenic T-cell lymphoma (HSTCL) -- Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) -- Mycosis fungoides (MF) -- Sezary syndrome (SS) -- Primary cutaneous CD30(+) lymphoproliferative disorders -- Lymphomatoid papulosis (LyP) -- Primary cutaneous anaplastic T-cell lymphoma (pcALCL) -- Primary cutaneous peripheral T-cell lymphoma (PTCL) -- Primary cutaneous TCRƒÁƒÂ(+) T-cell lymphoma (PCGD-TCL) -- Primary cutaneous CD8(+) aggressive epidermotropic cytotoxic T-cell lymphoma (PCAETL) -- Primary cutaneous acral CD8(+) T-cell lymphoma (PCATCL) -- Primary cutaneous lymphoma of the medium/small CD4(+) T cells (PCSM-TCL) -- Peripheral T-cell lymphoma, not otherwise specified (PTCLnos) -- Nodal lymphomas of follicular T-helper derivation -- Angioimmunoblastic T-cell lymphoma (AITL) -- Follicular T-cell lymphoma (FTCL) -- Nodal PTCL with follicular T-helper phenotype -- Anaplastic large cell lymphoma ALK(+) (ALCL ALK(+)). Anaplastic large cell lymphoma ALK(-) (ALCL ALK(-)) -- Breast implant.associated anaplastic large cell lymphoma (biaALCL) -- Hodgkin lymphomas -- Classic Hodgkin lymphoma (CHL) -- Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) -- Neoplastic diseases of histiocytic and dendritic cells -- Histiocytic sarcoma (HS) -- Langerhans cell histiocytosis (LCH) -- Indeterminate dendritic cell tumor (IDCT) -- Interdigitating dendritic cell sarcoma (IDCS) -- Follicular dendritic cell sarcoma (FDCS) -- Erdheim.Chester disease (EDC) -- Chapter 3 Appendix -- Acute leukemias not recognized by the 2017 WHO classification -- Acute leukemia of myeloid/NK precursors (M/NK-AL) -- Acute leukemia of myeloid dendritic cells (MDCL) -- Acute leukemia of Langerhans cells -- Composite lymphomas -- Hypereosinophilic syndrome (HES), lymphocyte variant -- Indolent T lymphoblastic proliferations (iT]LBP) -- Polyclonal lymphocytoses of B lymphocytes -- Persistent polyclonal B]cell lymphocytosis (PPBL) -- Persistent polyclonal CD5(+) B]cell lymphocytosis -- Persistent polyclonal B]cell lymphocytosis, Japanese (hairy) variant -- Polyclonal plasmacytoses -- Small round (blue) cell tumors (SR(B)CT) -- References -- Index -- EULA. |
| Record Nr. | UNINA-9910555117403321 |
Ortolani C (Claudio)
|
||
| Hoboken, New Jersey ; ; Chichester, West Sussex, England : , : Wiley Blackwell, , [2021] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Flow cytometry of hematological malignancies / / Claudio Ortolani
| Flow cytometry of hematological malignancies / / Claudio Ortolani |
| Autore | Ortolani C (Claudio) |
| Edizione | [Second edition.] |
| Pubbl/distr/stampa | Hoboken, New Jersey ; ; Chichester, West Sussex, England : , : Wiley Blackwell, , [2021] |
| Descrizione fisica | 1 online resource (467 pages) |
| Disciplina | 574.87028 |
| Soggetto topico |
Flow cytometry
Hematological oncology Flow cytometry - Methodology |
| ISBN |
1-119-61130-X
1-119-61127-X 1-119-61128-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover -- Title Page -- Copyright Page -- Contents -- Foreword to the Second Edition -- Foreword to the First Edition -- Foreword to the First Edition -- Preface to the Second Edition -- Preface to the First Edition -- Abbreviations -- Chapter 1 Antigens -- CD1 Antigens -- CD2 Antigen -- CD3 Antigen -- CD4 Antigen -- CD5 Antigen -- CD7 Antigen -- CD8 Antigen -- CD10 Antigen -- CD11b Antigen -- CD11c Antigen -- CD13 Antigen -- CD14 Antigen -- CD15 Antigen -- CD16 Antigen -- CD19 Antigen -- CD20 Antigen -- CD22 Antigen -- CD23 Antigen -- CD24 Antigen -- CD25 Antigen -- CD26 Antigen -- CD27 Antigen -- CD28 Antigen -- CD30 Antigen -- CD33 Antigen -- CD34 Antigen -- CD38 Antigen -- CD43 Antigen -- CD45 Antigen -- CD45 Isoforms -- CD49 Antigens -- CD56 Antigen -- CD57 Antigen -- CD61 Antigen -- CD62L Antigen -- CD64 Antigen -- CD65 Antigen -- CD66c Antigen -- CD71 Antigen -- CD79 Antigen -- CD81 Antigen -- CD103 Antigen -- CD117 Antigen -- CD123 Antigen -- CD138 Antigen -- CD200 Antigen -- CD305 Antigen -- CD307 (IRTA) Family -- CD371 Antigen -- BCL-2 Protein -- Chemokines and Chemokine Receptors -- Chemokines -- Chemokine Receptors -- CRLF2 Antigen -- Cytotoxic Proteins -- HLA-DR Antigen -- Immunoglobulins -- KIRs, CD158 Isoforms -- Myeloperoxidase -- NG2 Antigen -- PCA-1 Antigen -- ROR1 Antigen -- SLAM Molecules and SLAM-Associated Protein -- SOX11 -- T-Cell Receptor (TCR) -- Terminal Deoxy-Nucleotidyl Transferase -- Toll-Like Receptors -- VS38 Antigen -- ZAP-70 Protein -- Chapter 2 Diseases -- Myeloproliferative neoplasms -- Chronic myeloid leukemia (CML) -- Myeloproliferative neoplasms other than CML -- Chronic neutrophilic leukemia (CNL) -- Polycythemia vera (PV) -- Primary myelofibrosis (PMF) -- Essential thrombocythemia (ET) -- Chronic eosinophilic leukemia (CEL) -- Mastocytosis -- Acute mast-cell leukemia (AMCL).
Chronic mast-cell leukemia (CMCL) -- Myelomastocytic leukemia (MML) -- Myelodysplastic/myeloproliferative neoplasms -- Chronic myelomonocytic leukemia (CMML) -- Other myelodysplastic/myeloproliferative neoplasms and related conditions -- Juvenile myelomonocytic leukemia (JMML) -- Atypical CML bcr/abl negative (ACML) -- RAS-associated autoimmune leukoproliferative disorder (RALD) -- Myelodysplastic syndromes -- Myeloid neoplasms with germline predisposition -- Acute myeloid leukemias -- AMLs with recurrent genetic anomalies -- AMLs with chromosomal anomalies -- AMLs with gene mutations -- Relationships between genotype and phenotype in cases of AML not recognized as separate entities in WHO 2017 -- AMLs with myelodysplasia-related changes (AML-MRC) -- AMLs not otherwise specified -- AML with minimal differentiation -- AML without maturation -- AML with maturation -- Acute myelomonocytic leukemia (AMMoL) -- Acute monoblastic and monocytic leukemia (AMoL) -- Pure erythroid leukemia (PEL) -- Acute megakaryoblastic leukemia (AMKL) -- Acute basophilic leukemia (ABL) -- Myeloid proliferations associated with Down syndrome -- Transient abnormal myelopoiesis (TAM) -- AMLs in patients with Down syndrome -- Blastic plasmacytoid dendritic cell neoplasm (BPDCN/PDCL) -- Acute leukemias with ambiguous lineage attribution (ALAL) -- Acute undifferentiated leukemias (AUL) -- Mixed phenotype acute leukemias (MPAL) -- Neoplastic diseases of B and T lymphatic precursors -- B lymphoblastic leukemia/lymphoma, not otherwise specified (B-ALL/LBLnos) -- B lymphoblastic leukemia/lymphoma with recurrent genetic anomalies -- Relationships between genotype and phenotype in cases of B-ALL not recognized as separate entities in WHO 2017 -- T lymphoblastic leukemia/lymphoma (T-ALL/LBL) -- Early T-cell precursor lymphoblastic leukemia (ETP-ALL). NK lymphoblastic leukemia/lymphoma (NK-ALL/LBL) -- Neoplastic diseases of mature B cells -- Chronic lymphocytic leukemia/small lymphocytic lymphoma (B-CLL/SLL) -- Familial B-CLL -- Richter syndrome -- Monoclonal B-cell lymphocytosis (MBL) -- CLL-like monoclonal B lymphocytosis -- Non-CLL-like monoclonal B lymphocytosis -- B-cell prolymphocytic leukemia (B-PLL) -- Lymphoplasmacytic lymphoma (LPL) -- Heavy chain disease (HCD) -- μ heavy chain disease -- α heavy chain disease -- Hairy cell leukemia (HCL) -- Hairy cell leukemia, variant (HCL-v) -- Hairy cell leukemia, Japanese variant (HCL-J) -- Splenic diffuse red pulp lymphoma (SDRPL) -- Marginal zone lymphomas (MZL) -- Nodal marginal zone lymphoma (NMZL) -- Splenic marginal zone lymphoma (SMZL) -- Extranodal marginal zone lymphoma (EMZL/MALToma) -- Clonal B-cell lymphocytosis with MZL-like phenotype (CBL-MZ) -- Follicular lymphoma (FCL) -- Testicular follicular lymphoma -- Duodenal type follicular lymphoma -- Pediatric type follicular lymphoma -- Primitive cutaneous follicular lymphoma (PCFL) -- Large B-cell lymphoma with IRF4 rearrangement -- Mantle-cell lymphoma (MCL) -- Blastic mantle-cell lymphoma (BMCL) -- Leukemic non nodal mantle-cell lymphoma -- DLBCL not otherwise specified (DLBCLnos) -- CD5(+) diffuse large cell lymphoma (CD5(+) DLBCL) -- T-cell/histiocyte-rich B-cell lymphoma (THRLBCL) -- Primary DLBCL of the CNS (PCNSL) -- Primary cutaneous DLBCL, "leg type -- EBV(+) DLBCLnos -- DLBCL associated with chronic inflammation (PAL) -- Fibrin associated DLBCL -- Lymphomatoid granulomatosis (LYG) -- Primary mediastinal B-cell lymphoma (PMBCL) -- Intravascular large B-cell lymphoma (IVBCL) -- ALK-positive large cell lymphoma (ALK(+) LBCL) -- Plasmablastic lymphoma (PBL) -- Primary effusion lymphoma (PEL) -- HHV8-associated lymphoproliferative disorders -- HHV8-positive DLBCL. HHV8-positive germinotropic lymphoproliferative disorder -- Burkitt lymphoma (BL) -- Burkitt leukemia with immature phenotype -- Burkitt-like lymphoma with 11q aberrations -- High-grade B-cell lymphoma (HGBL) -- Plasma cell neoplasms -- Monoclonal gammopathies of undetermined significance (MGUS) -- Multiple myeloma (MM) -- Plasma cell leukemia (PCL) -- Neoplastic diseases of mature T and NK cells -- T-cell prolymphocytic leukemia (T-PLL) -- T-cell large granular lymphocytic leukemia (T-LGL) -- Chronic lymphoproliferative disorders of NK cells (CLPD-NK/CNKL) -- Aggressive NK-cell leukemia (ANKL) -- Adult T-cell leukemia/lymphoma (ATLL) -- Extranodal NK/T-cell lymphoma, "nasal type" (ENKTL) -- Intestinal T-cell lymphomas (ITCL) -- Enteropathy-associated T-cell lymphoma (EATCL) -- Monomorphic epitheliotropic intestinal T-cell lymphoma (MEITL) -- Indolent gastro-intestinal T lymphoproliferative disorder (indolent GI T-LPD) -- Hepatosplenic T-cell lymphoma (HSTCL) -- Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) -- Mycosis fungoides (MF) -- Sezary syndrome (SS) -- Primary cutaneous CD30(+) lymphoproliferative disorders -- Lymphomatoid papulosis (LyP) -- Primary cutaneous anaplastic T-cell lymphoma (pcALCL) -- Primary cutaneous peripheral T-cell lymphoma (PTCL) -- Primary cutaneous TCRƒÁƒÂ(+) T-cell lymphoma (PCGD-TCL) -- Primary cutaneous CD8(+) aggressive epidermotropic cytotoxic T-cell lymphoma (PCAETL) -- Primary cutaneous acral CD8(+) T-cell lymphoma (PCATCL) -- Primary cutaneous lymphoma of the medium/small CD4(+) T cells (PCSM-TCL) -- Peripheral T-cell lymphoma, not otherwise specified (PTCLnos) -- Nodal lymphomas of follicular T-helper derivation -- Angioimmunoblastic T-cell lymphoma (AITL) -- Follicular T-cell lymphoma (FTCL) -- Nodal PTCL with follicular T-helper phenotype -- Anaplastic large cell lymphoma ALK(+) (ALCL ALK(+)). Anaplastic large cell lymphoma ALK(-) (ALCL ALK(-)) -- Breast implant.associated anaplastic large cell lymphoma (biaALCL) -- Hodgkin lymphomas -- Classic Hodgkin lymphoma (CHL) -- Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) -- Neoplastic diseases of histiocytic and dendritic cells -- Histiocytic sarcoma (HS) -- Langerhans cell histiocytosis (LCH) -- Indeterminate dendritic cell tumor (IDCT) -- Interdigitating dendritic cell sarcoma (IDCS) -- Follicular dendritic cell sarcoma (FDCS) -- Erdheim.Chester disease (EDC) -- Chapter 3 Appendix -- Acute leukemias not recognized by the 2017 WHO classification -- Acute leukemia of myeloid/NK precursors (M/NK-AL) -- Acute leukemia of myeloid dendritic cells (MDCL) -- Acute leukemia of Langerhans cells -- Composite lymphomas -- Hypereosinophilic syndrome (HES), lymphocyte variant -- Indolent T lymphoblastic proliferations (iT]LBP) -- Polyclonal lymphocytoses of B lymphocytes -- Persistent polyclonal B]cell lymphocytosis (PPBL) -- Persistent polyclonal CD5(+) B]cell lymphocytosis -- Persistent polyclonal B]cell lymphocytosis, Japanese (hairy) variant -- Polyclonal plasmacytoses -- Small round (blue) cell tumors (SR(B)CT) -- References -- Index -- EULA. |
| Record Nr. | UNINA-9910829962903321 |
|
Ortolani C (Claudio)
|
||
| Hoboken, New Jersey ; ; Chichester, West Sussex, England : , : Wiley Blackwell, , [2021] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Flow Cytometry of Hematological Malignancies
| Flow Cytometry of Hematological Malignancies |
| Autore | Ortolani Claudio |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Hoboken, : Wiley, 2011 |
| Descrizione fisica | 1 online resource (327 p.) |
| Disciplina |
616.99/418
616.99418 616.9941807582 |
| Soggetto topico |
Flow cytometry
Flow Cytometry - methods Flow Cytometry -- methods Hematologic Neoplasms - diagnosis Hematologic Neoplasms -- diagnosis Hematological oncology Investigative Techniques Neoplasms by Site Cytophotometry Hematologic Diseases Fluorometry Cytological Techniques Neoplasms Hemic and Lymphatic Diseases Diseases Clinical Laboratory Techniques Luminescent Measurements Photometry Chemistry Techniques, Analytical Methods Diagnosis Hematologic Neoplasms Flow Cytometry Medicine Health & Biological Sciences Oncology |
| ISBN |
1-283-17847-8
9786613178473 1-4443-9806-7 1-4443-9804-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Flow Cytometry of Hematological Malignancies; Contents; Foreword by Maryalice Stetler-Stevenson; Foreword by Bruno Brando; Preface and acknowledgments; Abbreviations; 1 Antigens; CD1 Antigens; CD2 Antigen; CD3 Antigen; CD4 Antigen; CD5 Antigen; CD7 Antigen; CD8 Antigen; CD10 Antigen; CD11b Antigen; CD11c Antigen; CD13 Antigen; CD14 Antigen; CD15 Antigen; CD16 Antigen; CD19 Antigen; CD20 Antigen; CD22 Antigen; CD23 Antigen; CD24 Antigen; CD25 Antigen; CD30 Antigen; CD33 Antigen; CD34 Antigen; CD38 Antigen; CD45 Antigen; CD45 Isoforms; CD56 Antigen; CD57 Antigen; CD61 Antigen; CD64 Antigen
CD65 AntigenCD66c Antigen; CD71 Antigen; CD79 Antigen; CD103 Antigen; CD117 Antigen; CD138 Antigen; HLA-DR Antigen; NG2 Antigen; Immunoglobulins; Myeloperoxidase; Cytotoxic Proteins; KIR, CD158 Isoforms; T Cell Receptor; Terminal Deoxy-nucleotidyl Transferase; Bcl-2 Protein; ZAP-70 Protein; References; 2 Diseases; Myeloproliferative Neoplasms; Myelodysplastic/Myeloproliferative Neoplasms; Myelodysplastic Syndromes; Acute Myeloid Leukemias; Acute Leukemias of Ambigous Lineage Attribution; Acute Leukemias not Recognized by the WHO Classification Neoplastic Diseases of T and B Lymphatic PrecursorsNeoplastic Diseases of Mature B Cells; Neoplastic Diseases of Mature T and NK Cells; Appendix; References; Index; A; B; C; D; E; F; G; H; I; J; K; L; M; N; O; P; R; S; T; U; V; W; X; Z |
| Record Nr. | UNINA-9910139629903321 |
|
Ortolani Claudio
|
||
| Hoboken, : Wiley, 2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
The genetic basis of haematological cancers / / edited by Sabrina Tosi, Alistair Reid ; contributors Mary Alikian [and twenty one others]
| The genetic basis of haematological cancers / / edited by Sabrina Tosi, Alistair Reid ; contributors Mary Alikian [and twenty one others] |
| Pubbl/distr/stampa | Chichester, [England] : , : Wiley, , 2016 |
| Descrizione fisica | 1 online resource (398 p.) |
| Disciplina | 616.99/418042 |
| Soggetto topico |
Leukemia - Genetic aspects
Hematological oncology |
| ISBN |
1-118-52805-0
1-118-52803-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Molecular genetics of the myeloproliferative neoplasms / Philip A Beer -- Acute myeloid leukaemia / Dr Matthew L. Smith & Dr Thomas McKerrell -- Molecular genetics of pediatric acute myeloid leukemia (AML) / M.M. van den Heuvel-Eibrink, J.D.E. de Rooij, and C.M. Zwaan -- Acute lymphoblastic leukemia / Anna Andersson, Anthony V. Moorman, Christine J. Harrison and Charles Mullighan -- The genetics of mature b-cell malignancies / Jonathan C. Strefford, Jude Fitzgibbon, Matthew J.J. Rose-Zerilli and Csaba Bödör -- The genetics of chronic myelogenous leukaemia / Philippa C. May, Jamshid S. Khorashad, Mary Alikian, Danilo Perrotti and Alistair G. Reid. |
| Record Nr. | UNINA-9910136353603321 |
| Chichester, [England] : , : Wiley, , 2016 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Hematological oncology
| Hematological oncology |
| Pubbl/distr/stampa | [Chichester] ; ; [New York], : John Wiley & Sons |
| Descrizione fisica | 1 online resource |
| Disciplina | 616 |
| Soggetto topico |
Hematological oncology
Hematology Oncology Hematology - Periodicals Medical Oncology Hématologie - Périodiques Hématocancérologie Hématologie Cancérologie |
| Soggetto genere / forma |
Periodical
periodicals. Periodicals. Périodiques. |
| ISSN | 1099-1069 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Record Nr. | UNISA-996214164603316 |
| [Chichester] ; ; [New York], : John Wiley & Sons | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Hematological oncology
| Hematological oncology |
| Pubbl/distr/stampa | [Chichester] ; ; [New York], : John Wiley & Sons |
| Descrizione fisica | 1 online resource |
| Disciplina | 616 |
| Soggetto topico |
Hematological oncology
Hematology Oncology Hematology - Periodicals Medical Oncology Hématologie - Périodiques Hématocancérologie Hématologie Cancérologie |
| Soggetto genere / forma |
Periodical
periodicals. Periodicals. Périodiques. |
| ISSN | 1099-1069 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910142614403321 |
| [Chichester] ; ; [New York], : John Wiley & Sons | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
International journal of hematologic oncology
| International journal of hematologic oncology |
| Pubbl/distr/stampa | London, UK : , : Future Medicine, , [2012]- |
| Descrizione fisica | 1 online resource |
| Soggetto topico |
Hematological oncology
Hematologic Diseases Neoplasms |
| Soggetto genere / forma |
Periodical
Periodicals. |
| ISSN | 2045-1407 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Record Nr. | UNISA-996271550003316 |
| London, UK : , : Future Medicine, , [2012]- | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
International journal of hematologic oncology
| International journal of hematologic oncology |
| Pubbl/distr/stampa | London, UK : , : Future Medicine, , [2012]- |
| Descrizione fisica | 1 online resource |
| Soggetto topico |
Hematological oncology
Hematologic Diseases Neoplasms |
| Soggetto genere / forma |
Periodical
Periodicals. |
| ISSN | 2045-1407 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910287943903321 |
| London, UK : , : Future Medicine, , [2012]- | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Soggetto topico
-
Hematological oncology
(17)
- Oncology (6)
- Hematology (5)
- Neoplasms (5)
- Flow cytometry (3)